Adults with type 2 diabetes using a GLP-1 receptor agonist have a similar risk for developing thyroid cancer as those using a ...

The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The GLP-1 Receptor Agonist market has been expanding significantly in recent ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...